TURKISH JOURNAL OF PEDIATRICS, cilt.62, sa.4, ss.541-550, 2020 (SCI-Expanded, Scopus, TRDizin)
Background and objectives. Quantification of serum Epstein-Barr virus (EBV) DNA and/or cell-free total DNA (cf-DNA) may become valuable sources for prognosis evaluation and monitoring treatment response in lymphomas. We aimed to investigate their roles as potential markers in pediatric Hodgkin (HL) and non-Hodgkin lymphomas (NHL).